Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics
GET POWR RATINGS... FREE!
SPPI Stock Price Chart Interactive Chart >
SPPI Price/Volume Stats
| Current price | $0.82 | 52-week high | $1.57 |
| Prev. close | $0.81 | 52-week low | $0.32 |
| Day low | $0.80 | Volume | 1,129,800 |
| Day high | $0.83 | Avg. volume | 1,840,850 |
| 50-day MA | $0.49 | Dividend yield | N/A |
| 200-day MA | $0.72 | Market Cap | 154.26M |
Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio
Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.
Latest SPPI News From Around the Web
Below are the latest news stories about SPECTRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SPPI as an investment opportunity.
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively ParticipateNEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Spectrum common stock between December 6, 2021 through September 22, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by vi |
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmLOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm |
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmThe Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm |
Current Hot Stock Alert: Ideanomics, Inc. (NASDAQ:IDEX 0.00%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI 4.74%)IDEX has seen its SMA50 which is now 4.91%. In looking the SMA 200 we see that the stock has seen a -55.22%. SPPI has seen its SMA50 which is … The post Current Hot Stock Alert: Ideanomics, Inc. (NASDAQ:IDEX 0.00%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI 4.74%) appeared first on Stocks Equity . |
SPPI stock rises as early Q4 2022 sales exceed consensus (NASDAQ:SPPI)Micro-cap biotech Spectrum Pharmaceuticals (SPPI) jumped ~13% pre-market Tuesday after the company announced better than expected early sales for Q4 2022. Read the full story here. |
SPPI Price Returns
| 1-mo | 70.02% |
| 3-mo | 101.28% |
| 6-mo | -32.23% |
| 1-year | 22.26% |
| 3-year | -70.18% |
| 5-year | -95.85% |
| YTD | 122.52% |
| 2022 | -70.98% |
| 2021 | -62.76% |
| 2020 | -6.32% |
| 2019 | -58.40% |
| 2018 | -53.83% |
Continue Researching SPPI
Want to do more research on Spectrum Pharmaceuticals Inc's stock and its price? Try the links below:Spectrum Pharmaceuticals Inc (SPPI) Stock Price | Nasdaq
Spectrum Pharmaceuticals Inc (SPPI) Stock Quote, History and News - Yahoo Finance
Spectrum Pharmaceuticals Inc (SPPI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...